These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4016223)

  • 81. Recommended nomenclature for the spontaneously diabetic syndrome of the BB rat.
    Marliss EB
    Metabolism; 1983 Jul; 32(7 Suppl 1):6-7. PubMed ID: 6865769
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The oral hypoglycemic activity of 2,5-dioxamide derivatives of 1,3,4-thiadiazole.
    Oke JM; Olowookorun MO
    Jpn J Pharmacol; 1989 Jan; 49(1):135-8. PubMed ID: 2724675
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Sulfonyliminoimidazolidines. A new class of oral hypoglycemic agents. 1. 1-[[p-[2-(acylamino)ethyl]phenyl]sulfonyl]-2-iminoimidazolidines.
    Schweizer EH; Märki F; Lehmann C; Dietrich H
    J Med Chem; 1983 Jul; 26(7):964-70. PubMed ID: 6864736
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Genetic analysis of the BB/W diabetic rat.
    Butler L; Guberski DL; Like AA
    Can J Genet Cytol; 1983 Feb; 25(1):7-15. PubMed ID: 6839196
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Pancreatic beta-cell regeneration in rats by (-)-epicatechin.
    Chakravarthy BK; Gupta S; Gambhir SS; Gode KD
    Lancet; 1981 Oct; 2(8249):759-60. PubMed ID: 6116897
    [No Abstract]   [Full Text] [Related]  

  • 86. Hepatoprotective agents in alcoholic liver disease.
    Morgan MY
    Acta Med Scand Suppl; 1985; 703():225-33. PubMed ID: 3937442
    [No Abstract]   [Full Text] [Related]  

  • 87. (+)-Cyanidanol-3 in acute viral hepatitis.
    Di Nola F
    Lancet; 1980 Dec 20-27; 2(8208-8209):1379-80. PubMed ID: 6109203
    [No Abstract]   [Full Text] [Related]  

  • 88. Clinical applications and mechanism insights of natural flavonoids against type 2 diabetes mellitus.
    Bouyahya A; Balahbib A; Khalid A; Makeen HA; Alhazmi HA; Albratty M; Hermansyah A; Ming LC; Goh KW; El Omari N
    Heliyon; 2024 May; 10(9):e29718. PubMed ID: 38694079
    [TBL] [Abstract][Full Text] [Related]  

  • 89.
    Irfan Dar M; Qureshi MI; Zahiruddin S; Abass S; Jan B; Sultan A; Ahmad S
    ACS Omega; 2022 Dec; 7(50):46156-46173. PubMed ID: 36570189
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The Role of Catechins in Regulating Diabetes: An Update Review.
    Wen L; Wu D; Tan X; Zhong M; Xing J; Li W; Li D; Cao F
    Nutrients; 2022 Nov; 14(21):. PubMed ID: 36364943
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Metabolomic profiling to reveal the therapeutic potency of
    Ammar NM; Hassan HA; Mohammed MA; Serag A; Abd El-Alim SH; Elmotasem H; El Raey M; El Gendy AN; Sobeh M; Abdel-Hamid AZ
    RSC Adv; 2021 Feb; 11(14):8398-8410. PubMed ID: 35423335
    [No Abstract]   [Full Text] [Related]  

  • 92. Mechanisms Underlying the Antidiabetic Activities of Polyphenolic Compounds: A Review.
    Nie T; Cooper GJS
    Front Pharmacol; 2021; 12():798329. PubMed ID: 34970150
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Diet supplementation with green tea extract epigallocatechin gallate prevents progression to glucose intolerance in db/db mice.
    Ortsäter H; Grankvist N; Wolfram S; Kuehn N; Sjöholm A
    Nutr Metab (Lond); 2012 Feb; 9():11. PubMed ID: 22333133
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The lack of effectiveness of (-)-epicatechin against alloxan induced diabetes in Wistar rats.
    Sheehan EW; Stiff DD; Duah F; Slatkin DJ; Schiff PL; Zemaitis MA
    Life Sci; 1983 Aug; 33(7):593-7. PubMed ID: 6877034
    [TBL] [Abstract][Full Text] [Related]  

  • 95. A constituent of Pterocarpus marsupium, (-)-epicatechin, as a potential antidiabetic agent.
    Sheehan EW; Zemaitis MA; Slatkin DJ; Schiff PL
    J Nat Prod; 1983; 46(2):232-4. PubMed ID: 6875579
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Alloxan-induced diabetes, a common model for evaluating the glycemic-control potential of therapeutic compounds and plants extracts in experimental studies.
    Ighodaro OM; Adeosun AM; Akinloye OA
    Medicina (Kaunas); 2017; 53(6):365-374. PubMed ID: 29548636
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Assessment of the antidiabetic activity of epicatechin in streptozotocin-diabetic and spontaneously diabetic BB/E rats.
    Bone AJ; Hii CS; Brown D; Smith W; Howell SL
    Biosci Rep; 1985 Mar; 5(3):215-21. PubMed ID: 4016223
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Alloxan-induced diabetes in the rat - protective action of (-) epicatechin?
    Ryle PR; Barker J; Gaines PA; Thomson AD; Chakraborty J
    Life Sci; 1984 Feb; 34(6):591-5. PubMed ID: 6363864
    [TBL] [Abstract][Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.